(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3(Date:9/5/2008)... 5 /PRNewswire-USNewswire/ -- The Florida,Technolo...d Florida,Atlantic University researcher Dr. Herbe... of the Center for Molecular Biology and,Biotechno... and CHS,Resources LLC (CHS), $184,294 as part of ...sistance Grant program (SURECAG). SURECAG was,esta...
(Date:9/5/2008)...lif., Sept. 5 /- SARcode,Co...cule LFA-1 inhibitors,to treat inflammatory diseas...S) today announced SARcode,s initiation of a Phase...t candidate for T-cell mediated ophthalmic,disease...ement providing,SARcode with an exclusive license ...
(Date:9/4/2008)...ept. 4 /- Cytopia Limited (ASX:,CYT) ...r its Phase Ib/II,study of CYT997, the company,s n...ents with an aggressive form of brain cancer known...cal trial is the first Phase II efficacy study in ...ompany and the second in its,suite of Phase II stu...
(Date:9/4/2008)...Man(R) real-time PCR testing for the diagnostic ...alif., Sept. 4 /- The U.S. Food & Dru...S(R) TaqMan(R) HBV Test,the first assay for quant...,The test uses Roche,s real-time PCR technology to... patient,s blood. Doctors may use viral load,testi...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3The Polls are Open 21 America Votes to Decide Which Hospital is the Most Deserving of Siemens Newest MRI Technology 7786 1The Polls are Open 21 America Votes to Decide Which Hospital is the Most Deserving of Siemens Newest MRI Technology 7786 2The Polls are Open 21 America Votes to Decide Which Hospital is the Most Deserving of Siemens Newest MRI Technology 7786 3Neurochem announces eprodisate 28KIACTA 28TM 29 29 receives acknowledgement of complete response and is granted Class 2 review 7781 1Neurochem announces eprodisate 28KIACTA 28TM 29 29 receives acknowledgement of complete response and is granted Class 2 review 7781 2Neurochem announces eprodisate 28KIACTA 28TM 29 29 receives acknowledgement of complete response and is granted Class 2 review 7781 3AMWA Hosts Health Care Conversation With Congressman Kucinich 7776 1AMWA Hosts Health Care Conversation With Congressman Kucinich 7776 2St Jude finds mechanism for faulty protein disposal 7771 1St Jude finds mechanism for faulty protein disposal 7771 2St Jude finds mechanism for faulty protein disposal 7771 3St Jude finds mechanism for faulty protein disposal 7771 4...r ,According to the American Diabetes Associat... 2002 was estimated to be $132 billion, or one out...ed States. A chronic disease with no cure, diabete..., and gestational) marked by high levels of blood ...on, insulin action, or both. Nearly 20 million Ame...
...,Contributing Editor , ,Positive patient iden...diting bodies for the past few years. Until recen...re were beyond the reach of the average hospital o...th devices that can be integrated into a facilitys...er for small facilities, while others are best for...
Other Medicine Technology:Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control 2Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control 3Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model.
This double ended instrument was designed for delineating and lifting the corneal flap of previously performed lamellar refractive surgery cases.
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement.
Medicine Products: